Michael A. Papagikos

877 total citations
25 papers, 627 citations indexed

About

Michael A. Papagikos is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Otorhinolaryngology. According to data from OpenAlex, Michael A. Papagikos has authored 25 papers receiving a total of 627 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 8 papers in Radiation and 5 papers in Otorhinolaryngology. Recurrent topics in Michael A. Papagikos's work include Prostate Cancer Diagnosis and Treatment (10 papers), Prostate Cancer Treatment and Research (10 papers) and Advanced Radiotherapy Techniques (8 papers). Michael A. Papagikos is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (10 papers), Prostate Cancer Treatment and Research (10 papers) and Advanced Radiotherapy Techniques (8 papers). Michael A. Papagikos collaborates with scholars based in United States, Canada and Taiwan. Michael A. Papagikos's co-authors include W. Robert Lee, D. Neil Hayes, Peter E. Clark, Peter J. Rossi, David L. McCullough, Keith D. Eaton, Upendra Parvathaneni, Julie E. Bauman, Renato Martins and Jay J. Liao and has published in prestigious journals such as Journal of Clinical Oncology, The Lancet Oncology and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Michael A. Papagikos

25 papers receiving 612 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael A. Papagikos United States	13	408	165	140	125	121	25	627
Haruo Inokuchi Japan	14	240 0.6×	149 0.9×	123 0.9×	125 1.0×	128 1.1×	39	483
Hale Başak Çağlar Türkiye	15	465 1.1×	197 1.2×	88 0.6×	174 1.4×	194 1.6×	42	785
Sei‐Chul Yoon South Korea	15	200 0.5×	204 1.2×	109 0.8×	223 1.8×	144 1.2×	25	619
Rachit Kumar United States	17	326 0.8×	354 2.1×	176 1.3×	177 1.4×	94 0.8×	50	724
David S. Yoo United States	17	423 1.0×	163 1.0×	247 1.8×	187 1.5×	164 1.4×	39	841
Hsing‐Lung Chao Taiwan	17	283 0.7×	200 1.2×	142 1.0×	291 2.3×	209 1.7×	36	764
Hamid Raziee Canada	16	291 0.7×	178 1.1×	72 0.5×	150 1.2×	39 0.3×	40	646
Michelle Echevarria United States	9	252 0.6×	253 1.5×	46 0.3×	117 0.9×	165 1.4×	30	561
Daniel H. Schanne Switzerland	9	570 1.4×	325 2.0×	185 1.3×	183 1.5×	50 0.4×	19	860
A. Richetti Switzerland	13	253 0.6×	178 1.1×	215 1.5×	186 1.5×	136 1.1×	40	569

Countries citing papers authored by Michael A. Papagikos

Since Specialization

Citations

This map shows the geographic impact of Michael A. Papagikos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael A. Papagikos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael A. Papagikos more than expected).

Fields of papers citing papers by Michael A. Papagikos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael A. Papagikos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael A. Papagikos. The network helps show where Michael A. Papagikos may publish in the future.

Co-authorship network of co-authors of Michael A. Papagikos

This figure shows the co-authorship network connecting the top 25 collaborators of Michael A. Papagikos. A scholar is included among the top collaborators of Michael A. Papagikos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael A. Papagikos. Michael A. Papagikos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Michalski, Jeff M., Kathryn Winter, Bradley R. Prestidge, et al.. (2023). Effect of Brachytherapy With External Beam Radiation Therapy Versus Brachytherapy Alone for Intermediate-Risk Prostate Cancer: NRG Oncology RTOG 0232 Randomized Clinical Trial. Journal of Clinical Oncology. 41(24). 4035–4044. 18 indexed citations

Holmes, Jordan A., Roger F. Anderson, Timothy N. Showalter, et al.. (2018). Cardiovascular Preventive Care and Coordination of Care in Prostate Cancer Survivors: A Multi-Institutional Prospective Study. International Journal of Radiation Oncology*Biology*Physics. 103(1). 112–115. 13 indexed citations

Petty, W. Jeffrey, James J. Urbanic, Tamjeed Ahmed, et al.. (2018). Long-Term Outcomes of a Phase 2 Trial of Chemotherapy With Consolidative Radiation Therapy for Oligometastatic Non-Small Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics. 102(3). 527–535. 47 indexed citations

Boyer, Matthew J., et al.. (2017). Toxicity and quality of life report of a phase II study of stereotactic body radiotherapy (SBRT) for low and intermediate risk prostate cancer. Radiation Oncology. 12(1). 14–14. 23 indexed citations

Prestidge, Bradley R., Kathryn Winter, Martin G. Sanda, et al.. (2016). Initial Report of NRG Oncology/RTOG 0232: A Phase 3 Study Comparing Combined External Beam Radiation and Transperineal Interstitial Permanent Brachytherapy With Brachytherapy Alone for Selected Patients With Intermediate-Risk Prostatic Carcinoma. International Journal of Radiation Oncology*Biology*Physics. 96(2). S4–S4. 63 indexed citations

Boyer, Matthew J., et al.. (2016). Toxicity and Quality of Life Report of a Phase 2 Study of Stereotactic Body Radiation Therapy (SBRT) for Low- and Intermediate-Risk Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 96(2). E256–E257. 1 indexed citations

Austin, Melissa, Rodney A. Schmidt, Upendra Parvathaneni, et al.. (2012). Expression of p16, ERCC1, and EGFR amplification as predictors of responsiveness of locally advanced squamous cell carcinomas of head and neck (SCCHN) to cisplatin, radiotherapy, and erlotinib: A phase II randomized trial.. Journal of Clinical Oncology. 30(15_suppl). 5515–5515. 6 indexed citations

Maguire, Patrick D., Michael A. Papagikos, Charles R. Neal, et al.. (2010). Phase II Trial of Hyperfractionated Intensity-Modulated Radiation Therapy and Concurrent Weekly Cisplatin for Stage III and IVa Head-and-Neck Cancer. International Journal of Radiation Oncology*Biology*Physics. 79(4). 1081–1088. 29 indexed citations

Hayes, D. Neil, Michael A. Papagikos, F. Yunus, et al.. (2010). Multicenter randomized phase II trial of combined radiotherapy and cisplatin with or without erlotinib in patients with locally advanced squamous cell carcinoma of the head and neck (SCCAHN): Preliminary toxicity results.. Journal of Clinical Oncology. 28(15_suppl). 5580–5580. 8 indexed citations

10.

Wiant, D, Todd Atwood, John D. Olson, et al.. (2009). Gamma Knife^TMRadiosurgery Treatment Planning for Small Animals using High-Resolution 7T Micro-magnetic Resonance Imaging. Radiation Research. 172(5). 625–631. 7 indexed citations

11.

Papagikos, Michael A., Peter J. Rossi, James J. Urbanic, et al.. (2007). A Simple Model Predicts Freedom From Biochemical Recurrence After Low-Dose Rate Prostate Brachytherapy Alone. American Journal of Clinical Oncology. 30(2). 199–204. 3 indexed citations

12.

Green, Sylvan B., Abhay Sanan, Joseph M. Jenrette, et al.. (2006). GliaSite Brachytherapy for Treatment of Recurrent Malignant Gliomas: A Retrospective Multi-institutional Analysis. Neurosurgery. 58(4). 701–709. 97 indexed citations

13.

Papagikos, Michael A., et al.. (2006). 2307. International Journal of Radiation Oncology*Biology*Physics. 66(3). S381–S381. 1 indexed citations

14.

McMullen, Kevin P., Michael A. Papagikos, Steven S. Glazier, et al.. (2006). 2060. International Journal of Radiation Oncology*Biology*Physics. 66(3). S243–S244. 2 indexed citations

15.

Rossi, Peter J., Peter E. Clark, Michael A. Papagikos, David L. McCullough, & W. Robert Lee. (2006). Percentage of positive biopsies associated with freedom from biochemical recurrence after low-dose-rate prostate brachytherapy alone for clinically localized prostate cancer. Urology. 67(2). 349–353. 15 indexed citations

16.

Papagikos, Michael A., Edward G. Shaw, & Volker W. Stieber. (2005). Lessons learned from randomised clinical trials in adult low grade glioma. The Lancet Oncology. 6(4). 240–244. 21 indexed citations

17.

Papagikos, Michael A., Peter J. Rossi, & W. Robert Lee. (2005). Publication rate of abstracts from the annual ASTRO meeting: Comparison with other organizations. Journal of the American College of Radiology. 2(1). 72–75. 19 indexed citations

18.

Papagikos, Michael A., Allan F. deGuzman, Peter J. Rossi, et al.. (2005). Dosimetric quantifiers for low-dose-rate prostate brachytherapy: Is V100 superior to D90?. Brachytherapy. 4(4). 252–258. 45 indexed citations

19.

Sanan, Abhay, Kenneth Bastin, Joseph M. Jenrette, et al.. (2004). Gliasite radiotherapy system for treatment of recurrent malignant glioma: A multi-institutional analysis. International Journal of Radiation Oncology*Biology*Physics. 60(1). S258–S258. 1 indexed citations

20.

Papagikos, Michael A., Christopher H. Crane, John M. Skibber, et al.. (2003). Chemoradiation for adenocarcinoma of the anus. International Journal of Radiation Oncology*Biology*Physics. 55(3). 669–678. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact